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A catch-and-release receptor for the cholera toxin
Clare S. Mahon,*a,b Gemma C. Wildsmith,a Diksha Haksar,c Eyleen de Poel,d Jeffrey M. Beekman,d Roland J. Pieters,c Michael 
E. Webba and W. Bruce Turnbull,*a,b 
Stimuli-responsive receptors for the recognition unit of the cholera toxin (CTB) have been prepared by attaching multiple 
copies of its natural carbohydrate ligand, the GM1 oligosaccharide, to a thermoresponsive polymer scaffold. Below their 
lower critical solution temperature (LCST), polymers complex CTB with nanomolar affinity. When heated above their LCST, 
polymers undergo a reversible coil to globule transition which renders a proportion of the carbohydrate recognition motifs 
inaccessible to CTB. This thermally-modulated decrease in the avidity of the material for the protein has been used to 
reversibly capture CTB from solution, enabling its convenient isolation from a complex mixture.
Introduction
Interactions between proteins and other biological 
macromolecules or surfaces are crucial to the mediation of 
many physiological processes in healthy and diseased states,1 
and the development of synthetic materials which can perturb 
such interactions presents exciting opportunities for the 
production of new therapeutics and diagnostics.2, 3 Proteins 
often associate with their binding partners across large 
interface areas through multivalency,4 harnessing the effects of 
multiple weak interactions to produce strong adhesive forces. 
The construction of receptors or inhibitors using polymer-based 
systems allows for convenient access to the large molecular 
architectures required to bridge recognition sites on the 
surfaces of proteins, eliminating the need for the demanding 
synthesis of complex architectures such as dendrimers.5 The 
choice of a synthetic polymer scaffold for the construction of 
receptors also enables the inclusion of secondary functionality, 
such as compositional adaptivity,6, 7 or the ability to respond to 
environmental stimuli such as temperature8 or pH,9 to produce 
an adaptive material. 
The inclusion of thermoresponsive functionality within 
macromolecular receptors for proteins has yielded highly-
functional materials which allow for tunable recognition of their 
targets. Gibson and coworkers10 have produced temperature-
responsive nanoparticle-based receptors by immobilising 
polymers with -terminal aminogalactosyl units onto gold 
nanoparticles, along with a thermoresponsive polymer 
designed to act as a gate. Below the lower critical solution 
temperature (LCST) of the gate polymer, its steric bulk 
prevents the carbohydrate motifs from accessing the binding 
sites of soybean agglutinin (SBA), a complementary lectin. 
Heating the material induces collapse of the of the gate 
polymer, exposing carbohydrate units on the surface of the 
nanoparticles which are then able to complex with SBA. A 
similar strategy has been used to control the surface 
presentation of receptor targeting ligands on polymer-
decorated nanoparticles, and thereby control their endocytosis. 
Alexander and coworkers11 have decorated gold nanoparticles 
with transferritin, an iron transporting protein, along with a 
shielding thermoresponsive polymer. Below the LSCT of the 
polymer, nanoparticles display poor cellular uptake. An increase 
in temperature can be used to trigger collapse of the shielding 
polymer, exposing the transferrin ligands and inducing cellular 
uptake. An impressive catch-and-release system for a protein 
has been developed by Shea and coworkers,12 where 
multicomponent polymer nanoparticles were demonstrated 
only to complex lysozyme above their LCST, enabling their 
binding to the protein and subsequent release upon cooling. 
Surface-bound polymer brushes have also been employed for 
the selective adsorption of proteins, by tuning the ionic strength 
of the surrounding medium to modulate electrostatic 
interactions between proteins and surfaces.13
Here, we have constructed a high-affinity multivalent 
receptor for a bacterial protein on a thermally responsive 
polymer scaffold, and demonstrated that an increase in 
temperature above the LCST of the polymer may modulate this 
recognition  a feature we have used to enable the isolation of 
a single protein from a complex mixture.
Our thermoresponsive receptor binds to the carbohydrate 
recognition domain of the cholera toxin,14 a protein produced 
by Vibrio cholerae in the human intestine which is responsible 
for the acute diarrhoea associated with cholera. The cholera 
toxin is comprised of a single toxic A subunit and non-toxic B5 
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pentamer of identical units (CTB), each possessing a recognition 
site for the GM1 ganglioside (GM1), which is displayed on 
intestinal epithelial surfaces. The pentasaccharide unit of the 
ganglioside, the GM1 oligosaccharide (GM1os), has been 
demonstrated by isothermal titration calorimetry to display a 
remarkably high affinity for CTB, with a reported Kd of ~40 nM.
15 
Already, the incorporation of multiple copies of GM1os on 
macromolecular scaffolds16, 17 such as dendrimers,18 synthetic 
polymers19 or proteins20 has been shown to greatly enhance the 
inhibitory potency of recognition units, making CTB a 
particularly attractive target for the development of smart 
multivalent receptors and inhibitors.
Results and discussion
Synthesis of thermoresponsive receptor
We chose to construct our receptor on a poly(N-
isopropylacrylamide) (poly(NIPAm)) scaffold, a class of polymer 
well known for its ability to reversibly desolvate upon increases 
in solution temperature.21 NIPAm was copolymerised with tert-
butyl 2-methacryloylhydrazine-1-carboxylate (M1) (Scheme 1), 
which was prepared via hydrazinolysis of methacrylic 
anhydride,22 and subsequent BOC-protection of hydrazide 
units. RAFT polymerisation afforded a copolymer with a degree 
of polymerisation of approximately 99, displaying 
approximately 21 protected acylhydrazide functionalities as 
estimated using 1H NMR spectroscopy. Subsequent 
deprotection of P1 yielded the multiply acylhydrazide-
functionalised P2, which enabled the direct functionalisation of 
polymers with reducing sugars through the formation of
Scheme 1 Preparation of P2-GM1os. (i) N2H4.H2O, CHCl3, rt, 1 h. (ii) Di-tert-butyl 
dicarbonate, THF, rt, 24 h. (iii) S-Dodecyl-SJ"@KKJ"%
	"KJJ"
 
acid)trithiocarbonate, J"B1
@"	))


A DMSO, 70 °C, 18 h. (iv) 
50 % v/v CH3COOH, CH2Cl2, rt, 1 h. (v) EGCaseII, 25 mM NH4OAc, pH 5.0, 0.2 % v/v 
Triton X-100. (vi) 100 mM NH4OAc, pH 4.5, rt, 18 h.
-glycoside linkages (Scheme 1). This strategy has been used for 
the preparation of surface-immobilised carbohydrate 
microarrays,23 and avoids potentially complex synthetic 
modifications of the oligosaccharide in addition to presenting a 
general route to the production of receptors for other 
carbohydrate binding proteins. The GM1 ganglioside was 
treated with a bacterial endoglycoceramidase (EGCaseII, 
Rhodococcus sp. M-777) to yield GM1os,24, 25 which was 
combined with P2 under mildly acidic conditions to yield a 
polymer functionalised with multiple copies of GM1os (P2-
GM1os). 1H NMR spectroscopic analysis (ESI Fig. S2) confirmed 
the oligosaccharide to be displayed on the polymer primarily as 
its -glycoside. Dynamic light scattering (DLS) analysis (Fig. 2(c)) 
of P2-GM1os revealed a monomodal distribution with number 
average hydrodynamic diameter (Dh) of approximately 16 nm, a 
significant increase in hydrodynamic volume compared to P2, 
which displayed a Dh of approximately 5 nm.
Assessment of inhibitory potency of P2-GM1os for CTB
As other multivalent receptors for CTB have previously proven 
effective in inhibiting adhesion of the cholera toxin to GM1 
functionalised surfaces, 26, 27 we decided to investigate this 
effect with our system. Initially, the inhibitory potency of P2-
GM1os towards CTB was assessed using an enzyme-linked 
lectin assay (ELLA, Fig. 1),20 where the ability of CTB to bind to 
surface- immobilised GM1 was assessed over a range of P2-
GM1os concentrations (Table 1) at 25 °C. P2-GM1os 
demonstrated an IC50 value of 3.78 nM, a significant 
enhancement in inhibitory potency compared to GM1os (Table 
1, 505 nM), demonstrating that P2-GM1os can effectively 
disrupt interactions between CTB and surfaces displaying 
GM1os.  We next investigated the ability of P2-GM1os to 
prevent the entry of the cholera toxin to human cells, using an 
intestinal organoid assay.28 In this assay, intestinal organoids 
are exposed to the cholera toxin over a range of inhibitor 
concentrations, and inhibition is monitored by assessing the 
ability of the cholera toxin to enter the cells and to induce fluid 
secretion leading to an increase in organoid surface area.  P2-
GM1os was found to be a potent inhibitor of cholera toxin 
induced swelling, with an IC50 value of 5.68 nM, demonstrating 
an impressive improvement in inhibitory 
Fig. 1 Enzyme-linked lectin assay (ELLA) indicates the inhibitory potency of P2-GM1os 
compared to GM1os at 293 K. Error bars indicate the standard error of three 
measurements.
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Table 1 Inhibitory potencies from enzyme-linked lectin assay (ELLA) and intestinal 
organoid assay. Curves were fitted using log[inhibitor] values, leading to the asymmetric 
distribution of fitting errors about the mean. These errors have therefore been omitted 
for simplicity. [a] Potency is expressed relative to monovalent GM1os in the 
corresponding assay.
Assay Inhibitor Valency log[IC50] IC50
 / 
nM 
Relative 
potency 
(per 
GM1os)
ELLA GM1os 1 -6.30 ± 
0.08
505 1
ELLA P2-GM1os 21 -8.42 ± 
0.14
3.78 6.38
Intestinal 
organoid 
assay
GM1os 1 -5.06 ± 
0.11
8700 1
Intestinal 
organoid 
assay
P2-GM1os 21 -8.30 ± 
0.16
5.68 72.9
potency compared to GM1os (Table 1, 8.7 µM). These results 
demonstrate that the complexation of CTB by P2-GM1os can be 
harnessed to prevent the internalisation of the cholera toxin by 
intestinal cells. Synthetic multivalent inhibitors of cellular 
adhesion such as P2-GM1os may offer therapeutic potential for 
diseases caused by bacterial toxins, offering an attractive 
antibiotic-free route to the control of symptoms.29
Thermoresponsive behaviour
The thermoresponsive properties of P2 and P2-GM1os were 
investigated by turbidimetry,21 (Fig. 2(a),(b)) providing an 
estimate of the LCST of each polymer. P2 was observed to 
undergo a sharp phase transition with a cloud point of 44 °C at 
2.0 mg mL-1 in phosphate-buffered saline (137 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4 - PBS). The 
analogous transition for P2-GM1os was observed to occur with 
a similar cloud point of 48 °C under the same conditions, but 
with the transition occurring over a broader temperature range, 
a feature we attribute to the numerous hydrogen bonding units 
incorporated onto P2 by its functionalisation with GM1os. The 
cloud point determined for P2-GM1os by turbidimetry was in 
agreement with variable-temperature dynamic light scattering 
experiments conducted at 0.5 mg mL-1 in the same buffer (Fig. 
2(d)), which showed the formation of large aggregates in 
solution around this temperature. We hypothesised that this 
triggered phase transition could be used to modulate the 
affinity of P2-GM1os for CTB, and decided to probe this 
hypothesis using isothermal titration calorimetry (ITC).
Isothermal titration calorimetry studies
Initially, recognition was investigated at 25 C, below the LCST 
of the polymer, when chains adopt a hydrated coil 
conformation. Under these conditions, CTB was observed to 
recognise GM1os with a Kd of 37.9 nM (± 3.7 nM) (Fig. 3(a), 
Table 2). P2-GM1os also displayed nanomolar affinity for CTB, 
with an apparent Kd of 31.4 nM (± 4.1 nM) and a binding 
Fig. 2  Temperature-turbidity curves for P2 (a) and P2-GM1os (b) at 2.0 mg mL-1 in PBS, 
pH 7.4 (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4). (c) Number 
average hydrodynamic diameters (Dh) for P2 and P2-GM1os at 25 °C in PBS pH 7.4. (d) 
Number average Dh for P2-GM1os across the temperature range 20-80 °C. Error bars 
represent the standard distribution of at least five measurements. (e) The reversible 
desolvation of P2-GM1os at temperatures above its LCST.
stoichiometry of 15 CTB subunits per polymer chain, 
demonstrating that multiple GM1os residues on each polymer 
can interact with CTB with a similar affinity to that observed for 
the monovalent interaction. The apparent lack of improvement 
in Kd, despite a significant enhancement in inhibitory potency, 
has been observed previously with other multivalent inhibitors 
of CTB.20, 30 We next repeated these experiments at 60 C, 
above the LCST of the polymer, when polymer chains are 
expected to exist in a collapsed, globular conformation. At this 
temperature CTB, which has been determined to be thermally 
stable at temperatures of up to 74 C,31 was shown to recognise 
GM1os with a Kd of 4.46 µM (± 0.43 µM) (Fig. 3(c), Table 2). This 
decrease in affinity at elevated temperature may be accounted 
for by the unfavourable entropic contribution to binding, and in 
particular the increase in flexibility of the loop around the 
carbohydrate recognition site of the protein.32 Under these 
conditions, P2- GM1os binds CTB with an apparent Kd of 3.66 
µM (± 0.81 µM) (Fig. 3(d), Table 2), similar to the monovalent 
interaction. Notably, however, the binding stoichiometry of the 
interaction decreased to 9.9, suggesting fewer GM1os residues 
per polymer chain interact with CTB at elevated temperature. 
We propose that the thermally-triggered collapse of P2-GM1os 
renders a proportion of GM1os recognition units inaccessible to 
CTB on the interior of the globule, whilst the GM1os residues 
which remain on the surface still interact with CTB with a 
comparable affinity to the monovalent interaction. We 
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Table 2 Thermodynamic parameters for GM1os and P2-GM1os binding to CTB at 25 C 
and at 60 C. Titrations were performed in PBS at pH 7.4 (137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2PO4). *binding stoichiometry fixed during fitting.
Temp. 
/ C
Ligand Kd (app) / 
nM @TA
U2 / 
kcal 
mol-1 
@TA
U5 / 
kcal 
mol-1 
@TA
U / 
cal K-1 
mol-1 
@TA
n @TA
25 GM1os 37.9 
(3.7)
-10.1
(1.0)
-20.5 
(0.1)
-34.9
(4.9)
1.0
(0.004)
25 P2-GM1os 31.4 
(4.1)
-10.2
(1.3)
-20.8 
(0.2)
-35.5
(6.5)
14.8
(0.07)
60 GM1os 4460 
(430)
-8.15
(0.8)
-30.1 
(0.9)
-66.0
(8.9)
1.0*
60 P2-GM1os 3660
(810)
-8.29
(1.83)
-34.2
(4.3)
-77.7
(19.7)
9.9
(0.99)
hypothesised that this thermally-induced change in binding 
stoichiometry could be harnessed to modulate the overall 
avidity of the material for CTB. With this aim in mind, we 
immobilised P2-GM1os onto a solid support, to investigate if 
the polymer could be used to facilitate catch-and-release 
isolation of the protein.
Reversible complexation of CTB
P2-GM1os was conveniently immobilised onto a solid support 
in a in a one-pot procedure. The trithiocarbonate end groups of 
were first converted to thiols by aminolysis, and immediately 
Scheme 2 Immobilisation of P2-GM1os onto maleimide-functionalised agarose beads. (i) 
hexylamine, Et3N, DMSO. 
Fig. 4 The catch-and-release behaviour of P2-GM1os functionalised beads applied to (a) 
a 10 µM solution of CTB in PBS pH 7.4; and (b) Vibrio sp60 growth medium, as 
demonstrated by gel electrophoresis. In each case lane 1 contains the analyte; lane 2 
beads after exposure to analyte; lane 3 the supernatant after analyte loading; lanes 4 
and 5 contain the bead washes with PBS at room temperature; lane 6 contains the eluate 
obtained after treatment with PBS at 60 °C and lane 7 the beads after elution. Gels were 
stained using Coomassie blue (a); or silver stain (b).
subjected to thiol-ene  coupling33 with commercially available 
maleimide functionalised agarose beads (Scheme 2).  Upon 
incubation with a 10 µM solution of CTB in PBS, beads were 
shown to complex with CTB using gel electrophoresis (Fig 4(a)). 
The CTB complexed with the beads was not eluted during 
washes with PBS at ambient temperature, but when incubated 
with the same buffer at 60 °C, above the determined LCST of P2-
GM1os, CTB was successfully recovered from the beads. To 
determine if this catch-and-release12 behaviour could 
translate to the isolation of a single protein from a highly 
complex mixture, we attempted to isolate CTB from a solution 
of Vibrio sp60 growth medium in which CTB is expressed, and 
exported from the cells to the surrounding medium. The cells 
were separated from the rest of the growth medium by 
centrifugation, and the supernatant incubated with P2-GM1os 
functionalised beads at room temperature. The beads were 
washed with PBS at room temperature to remove any weakly 
adhering material, before treatment with the same buffer at 60 
°C triggered elution of CTB (Fig. 4(b)). This response 
demonstrates that the combined effects of high-affinity 
multivalent recognition and the stimuli-responsive nature of 
our polymer scaffold may be used to selectively isolate a single 
bacterial toxin from a complex biological medium. 
Conclusions
In summary, we report a stimuli-responsive receptor which can 
complex CTB with nanomolar affinity, and release the protein 
on demand in response to a thermal stimulus. Our polymeric 
receptor has been shown to be effective in preventing the 
internalisation of the cholera toxin by intestinal cells, with 
inhibitory potency in the low nanomolar range. The 
temperature-mediated catch-and-release behaviour has been 
used to isolate CTB from bacterial growth medium, a complex 
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biological medium containing a multitude of other proteins. 
Current gold-standard identification protocols for cholera34 
and other diarrheal diseases rely on bacterial culture, processes 
which require time and access to appropriate facilities. We 
anticipate that our system could contribute to the development 
of diagnostics for diseases such as cholera, by providing a route 
to conveniently isolate the toxin for identification. 
Finally, our method presents a straightforward route to the 
synthesis of highly functional multivalent receptors for lectins, 
incorporating carbohydrate recognition motifs directly from 
reducing sugars. Our approach could be easily adapted to 
enable the production of receptors for the many other 
carbohydrate-binding proteins implicated in bacterial disease,16 
by judicious choice of carbohydrate recognition units. 
Experimental
Materials and characterisation
All reagents were purchased from Sigma Aldrich, Alfa Aesar, 
Carbosynth or Fluorochem and used as received unless 
otherwise stated. N-isopropylacrylamide was recrystallised 
from hexane prior to use. Phosphate buffered saline (PBS) 
refers to a solution of 137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4 and 1.8 mM KH2PO4 in MilliQ water. 
1H and 13C NMR 
spectra were recorded on a Bruker Avance 500 spectrometer at 
500 MHz and 125 MHz respectively, with the residual solvent 
signal as an internal standard. Mass spectra were collected 
using a Bruker MicroTOF instrument. Gel permeation 
chromatography (GPC) was conducted on a Varian ProStar 
instrument (Varian Inc.) equipped with a Varian 325 UV-Vis dual 
wavelength detector (254 nm), a Dawn Heleos II multi-angle 
laser light scattering detector (Wyatt Technology Corp.), a 
Viscotek 3580 differential RI detector, and a pair of PL gel 5 X 
Mixed D 300 × 7.5 mm columns with guard column (Polymer 
Laboratories Inc.) in series. Near monodisperse methyl 
methacrylate standards (Agilent Technologies) were used for 
calibration. Data collection was performed with Galaxie 
software (Varian Inc.) and chromatograms analyzed with Cirrus 
software (Varian Inc.) and Astra software (Wyatt Technology 
Corp.). Turbidimetric analysis was performed on a Cary 100 UV-
Vis spectrometer, with the absorbance of 2.0 mg mL-1 solutions 
monitored at 550 nm. Cloud points are reported as the mid-
point of a fit to a standard dose-response curve in Origin 8. 
Dynamic light scattering (DLS) instrumentation consisted of a 
Malvern Zetasizer µV with a 633 nm HeNe laser module. 
Measurements were made at an angle of 173 ° (back scattering) 
and Malvern Zetasizer software was used to analyse the data. 
Solutions were filtered through a 0.22 µm PTFE filter prior to 
analysis. At each temperature point the solution was incubated 
for 30 min before measurements were made. 
Methacryloyl hydrazide22 (1) 
Methacrylic anhydride (9.6 mL, 65 mmol) in CHCl3 (50 mL) was 
added dropwise to hydrazine hydrate (13.2 mL, 27 mmol) at 0 
°C. The mixture was left to stir at room temperature for 1 h, 
then the organic fraction was removed. The aqueous fraction 
was extracted with CHCl3 (3 × 25 mL) and the combined organic 
extracts were dried over MgSO4 and evaporated to dryness, 
yielding a while solid. The title product was recrystallised from 
10:1 toluene : CH2Cl2 and isolated as colourless, needle-like 
crystals (2.50 g, 38%). 1H NMR (500 MHz, CDCl3): [ 1.95 (s, 3H, 
CH3), 3.98 (s, 2H, NH2), 5.35 (s, 1H, CH2), 5.71 (s, 1H, CH2), 7.39 
(s, 1H, NH). 13C NMR (125 MHz, CDCl3): [ 18.5, 120.5, 138.2, 
169.5. Melting point  83.0  86.5 °C (84  86 °C22). ESI-HRMS: 
calculated for C4O2N2H9 [M + H
+]: 101.0709; found 101.0019.   
tert-Butyl 2-methacryloylhydrazine-1-carboxylate35 (M1) 
Di-tert-butyl dicarbonate (5.12 g, 24 mmol) in THF (50 mL) was 
added dropwise to 1 (2.38 g, 24 mmol) in THF (50 mL). The 
reaction mixture was left to stir at room temperature for 24 h 
before it was evaporated to dryness. The white solid obtained 
was dissolved in CH2Cl2 (100 mL) and washed with sat. NaCl(aq) 
(100 mL). The organic fraction was dried over MgSO4 and 
evaporated to dryness, yielding a white solid. M1 was 
recrystallised from 10:1 toluene : CH2Cl2 and isolated as white 
crystals (2.65 g, 55 %). 1H NMR (500 MHz, CDCl3): [ 1.47 (s, 9H, 
C(CH3)3), 1.98 (s, 3H, CH3), 5.42 (s, 1H, CH2), 5.81 (s, 1H, CH2), 
6.70 (s, 1H, NHNHCOC(CH3)3), 7.89 (s, 1H, NHNHCO C(CH3)3). 
13C 
NMR (125 MHz, CDCl3): [ 18.5, 28.3, 82.1, 83.62, 133.3, 155.7, 
167.8. Melting point: 115.5  117.6 °C. ESI-HRMS: calculated for 
C9H16N2NaO3 [M + Na
+]: 223.1053; found 223.1057. 
BOC-protected acylhydrazide copolymer P1
S-1-Dodecyl-S"@KK"%
	"K??"
 acid)trithiocarbonate36 
(DDMAT) (20 mg, 5.5 × 10-5 mol, 1.0 eq.), ="=>-
azoisobutyronitrile (AIBN) (1.8 mg,  1.1 × 10-5 mol, 0.2 eq.), N-
isopropylacrylamide (NIPAm) (0.993 g, 8.78 mmol, 160 eq.) and 
M1 (0.241 g, 1.20 mmol, 20 eq.) were combined in DMSO (3 mL) 
and degassed via three freeze-pump-thaw cycles. The vessel 
was backfilled with N2(g) and allowed to warm to room 
temperature, then placed in a preheated oil bath at 70 °C for 18 
h. The polymerisation was quenched by rapid cooling in N2(l), 
followed by exposure to air. The solution was added dropwise 
to a large excess of ice-cold diethyl ether, yielding a yellow-
white solid which was redissolved in THF and the precipitation 
repeated twice before drying under high vacuum. P1 was 
isolated as a yellow-white solid (0.350 g). 1H NMR (500 MHz, 
CDCl3): [ 1.15 (br, NHCH(CH3)3), 1.48 (br, (COOC(CH3)3), 1.6  1.9 
(br, (CH2, CH3), polymer backbone), 2  2.4 (br, (CH), polymer 
backbone, 3.04 (br, NHCHCH3), 4.01 (br, NHCHCH3), 6.0-7.0 (br, 
NHNHCOOC(CH3)3).
Acylhydrazide copolymer P2
P1 (30 mg, 2.2 × 10-6 mol) was dissolved in CH2Cl2 (1 mL). 
Trifluoroacetic acid (1 mL) was added and the solution was left 
to stir at room temperature for 1 h. The solution was 
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concentrated in vacuo, yielding a yellow glassy film which was 
redissolved in H2O, dialysed against H2O and lyophilised, 
yielding P2 as a yellow-white solid (21 mg, 83% yield). 1H NMR 
(500 MHz, CDCl3): [ 1.13 (br, NHCH(CH3)3, polymer backbone), 
1.6  1.9 (br, (CH2, CH3), polymer backbone), 2  2.4 (br, (CH), 
polymer backbone, 4.01 (br, NHCHCH3).
GM1os functionalised copolymer P2-GM1os
GM1os (6.2 mg, 6.1 x 10-6 mol) and P2 (3.0 mg, 2.6 × 10-6 mol) 
were combined in 100 mM NH4OAc, pH 4.5, D2O (500 µL). The 
solution was left to stir at room temperature for 24 h. The 
solution was then dialysed against H2O and lyophilised, yielding 
the title product as a yellow-white solid (3.5 mg, 41% yield). 1H 
NMR (500 MHz, D2O): ESI Fig. S2.
GM1os preparation15
GM1 ganglioside (100 mg, 6.37 × 10-5  mol) and BSA (2.0 mg) 
were dissolved in 25 mM NH4OAc, pH 5.0, 0.2% v/v Triton X-100 
(9 mL). The solution was split into 450 µL aliquots, to which 
EGCaseII (50 µL at 100 µM in 20 mM Na2HPO4, pH 7.0, 500 mM 
NaCl) was added. The solutions were incubated at 37 °C for 12 
days, at which point TLC analysis confirmed complete reaction 
of the ganglioside. The solutions were combined and washed 
with Et2O (2 × 10 mL), before the combined aqueous fraction 
was passed through a 0.45 µm syringe filter, then loaded onto a 
C18 solid phase extraction cartridge and eluted with H2O. 
Fractions containing GM1os were combined and twice 
lyophilised from H2O, yielding GM1os as a white solid (50.7 mg, 
4.97 × 10-5 mol, 78% yield). The 1H NMR spectrum recorded (ESI 
Fig. S13) is in agreement with previous reports.37
Immobilisation of P2-GM1os onto agarose beads
Procedure adapted from Boyer et al.33 Maleimide 
functionalised agarose beads (Cube Biotech.) (500 µL 
suspension) were washed with H2O (3 × 1 mL) and lyophilised. 
P2-GM1os (3.2 mg, 1.0 × 10-7 mol, 1.0 eq.) was dissolved in 
DMSO (600 µL). The solution was sparged with N2(g) before 
addition of Et3N (25 µL, 1.8 × 10
-5 mol, 180 eq.) and hexylamine 
(64 µL, 4.5 × 10-4 mol, 4500 eq.). The suspension was left to stir 
at room temperature for 16 h, then beads were isolated by 
centrifugation (500g, 1 min). The supernatant was removed and 
the beads were washed with H2O (3 × 1 mL), PBS pH 7.4 (3 × 1 
mL) and resuspended in 2 mM -mercaptoethanol in PBS (500 
µL). The suspension was agitated gently at room temperature 
for 2 h, then beads were isolated by centrifugation (500 g, 1 
min), washed with PBS pH 7.4 (3 × 1 mL), H2O (3 x 1 mL) and 
stored in 20% v/v EtOH(aq). UV-Vis spectra of the initial solution 
of P2-GM1os were compared to that of the supernatant after 
coupling (Fig. S4), with the loss of the absorbance of the 
trithiocarbonate unit at 309 nm demonstrating reduction of 
polymer end groups.
Isothermal titration calorimetry (ITC)
CTB samples were dialysed into PBS using SpectraPor dialysis 
tubing (MWCO 2.5  3 kDa, SpectrumLabs). P2-GM1os samples 
were dialysed against MilliQ H2O, lyophilised and dissolved in 
the same buffer solution. The concentration of GM1os solutions 
in MilliQ H2O were determined using 
1H NMR spectroscopic 
analysis15 using EtOH as an internal standard. These solutions 
were then lyophilised and reconstituted in the CTB dialysis 
buffer prior to the titration to ensure an exact buffer match 
during the experiment. Concentrations of CTB stated refer to 
the concentrations of the subunits. 
The reference cell was filled with water and the analysis cell 
filled with P2-GM1os in the case of P2-GM1os  CTB titrations, 
or CTB in the case of GM1os  CTB titrations. Both cells were 
allowed to reach thermal equilibrium at 25 C, or 60 C, before 
titration. Titrations typically consisted of a single 2 µL injection, 
followed by 29  8 µL injections when using the VP-ITC 
instrument, and single 0.5 µL injection, followed by 19  2 µL 
injections when using the ITC-200 instrument. Separate 
titrations of the binding partner in the syringe into buffer were 
used to assess the heat of dilution. 
Protocol for reversible complexation of CTB
P2-GM1os beads (stored in 20% v/v EtOH(aq)) were isolated by 
centrifugation (500g, 1 min) and resuspended in 10 µM CTB in 
PBS, pH 7.4 (500 µL). The tube was agitated gently at room 
temperature for 1 h before the beads were isolated by 
centrifugation (500g, 1 min) and the supernatant removed. 
P2-GM1os beads were washed with PBS (2 × 500 µL) at room 
temperature, then incubated at 60 °C in preheated PBS for 15 
min. Beads were isolated by centrifugation (500 g, 30 s) and the 
elution repeated.
Protocol for purification of CTB from bacterial growth medium
Cells from a glycerol stock of Vibrio sp60 harbouring plasmid 
pATA1338 (kindly provided by Prof. Tim Hirst) were used to 
inoculate growth medium (100 mL, 25 g L-1 LB mix, 15 g L-1 NaCl, 
ampicillin 100 µgmL-1). The culture was grown overnight at 30 
°C with shaking at 200 rpm, then used to inoculate fresh growth 
medium (6 × 1 L, 25 g L-1 LB mix, 15 g L-1 NaCl, ampicillin 100 µg 
mL-1). These cultures were incubated at 30 °C with shaking at 
200 rpm until A600 reached 0.6 before the protein expression 
was induced by addition of isopropyl ]"D-1-
thiogalactopyranoside to a concentration of 0.5 mM. Cultures 
were incubated (30 °C, 200 rpm) for a further 24 h, then cells 
were removed by centrifugation (7500g, 15 min). P2-GM1os 
beads (stored in 20% v/v EtOH(aq)) were isolated by 
centrifugation (500g, 1 min) and resuspended in the 
supernatant (4 × 500 µL) with a 15 min incubation time and 
gentle agitation at room temperature. The beads were isolated 
by centrifugation (500 g, 1 min) and the supernatant removed. 
P2-GM1os beads were washed with PBS (2 × 500 µL) at room 
temperature, the incubated at 60 °C in preheated PBS for 
15 min. Beads were isolated by centrifugation (500g, 30 s) and 
the elution repeated.
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Enzyme-linked lectin assay20 (ELLA)
96 well high-binding black flat bottomed plates were treated 
with 1.3 µM GM1 ganglioside in EtOH (100 µL/well), and the 
solution was left to evaporate under laminar flow overnight. 
Wells were washed with PBS (3 × 200 µL) before treatment with 
1.0% w/v bovine serum albumin (BSA) in PBS (100 µL) for 30 min 
at 37 °C. Wells were then washed with PBS (3 × 200 µL). 
Inhibitor solutions were prepared in 0.1% w/v BSA, 0.05% 
Tween 20, PBS, pH 7.4 (521 µM GM1os, 100 µM P2-GM1os). 
The concentration of GM1os was determined by 1H NMR 
spectroscopic analysis using EtOH as an internal standard.15 A 
24-step three-fold dilution series of both inhibitor solutions was 
performed in triplicate. Each solution was combined with a CTB-
horseradish peroxidase conjugate (CTB-HRP) at 5.0 ng mL-1 CTB-
HRP, 0.01% w/v BSA, 0.05% Tween 20, PBS, pH 7.4. These 
inhibitor-toxin solutions were allowed to incubate at room 
temperature for 2 h, then were transferred to GM1 
functionalised plates (200 µL/well). The plates were left at room 
temperature for 30 min , then emptied and wells were washed 
with 0.1% w/v BSA, 0.05% Tween 20, PBS, pH 7.4 (3 × 200 µL). 
5 µM H2O2, 5 µM Amplex red, PBS, pH 7.4 (100 µL) was added 
and fluorescence was monitored over a 5 min period (ex 531 
nm, em 595 nm) at 25 °C. The slope of each plot of fluorescence 
intensity against time was recorded and these values were 
plotted against log[inhibitor] and fitted using a standard dose-
response model in Origin 8.
Human rectal biopsies
Rectal biopsies were collected from a healthy human subject 
after acquiring approval  by the Ethics Committee of the 
University Medical Center Utrecht (UMCU) and after obtaining 
informed consent of the individual.
Generating and culturing organoids
The generation and biobanking of the intestinal organoids 
differed slightly from previously described protocols.39 After 
washing with PBS, crypts were isolated from the biopsies, via 
60-90 min incubation in 10 mM EDTA at 4 °C on  a rocking 
platform. Crypts were collected, centrifuged at 130g for 5 min 
at 4 °C, and supernatant removed. Crypts pellet was 
resuspended in 50% Matrigel (Corning, diluted in culture 
medium), and droplets of crypts suspension were plated onto 
pre-warmed 24-well plates. After polymerization of the 
Matrigel (±15 min, 37 °C/5% CO2), droplets were immersed in 
culture medium (advanced DMEM/F12 supplemented with 
HEPES, GlutaMAX, penicillin, streptomycin, N-2, B-27, mEGF (50 
ng/ml, Life Technologies), N-acetylcysteine (1.25 mM), 
nicotinamide (10 mM), SB202190 (10 X/ Sigma), A83-01 (500 
nM Tocris),  prymocin (100 X&. Invivogen), and 50% Wnt3a-, 
20% Rspo-1-, and 10% Noggin-conditioned media). In 5-9 days, 
crypts grew out into full grown organoids, which were passaged 
via mechanical disruption of the organoids. Medium was 
refreshed every ^! days, and organoids were passaged at least 
two times before assays were performed.
Organoid swelling assay
CFTR function measurements in intestinal organoids was 
performed slightly differently than the previously described 
procedures.26,39 Organoids cultured for 6-8 days were 
mechanically disrupted and seeded into flat-bottom 96-well 
plates in 50% Matrigel and incubated overnight at 37 °C, 5% 
CO2. The next day, cholera toxin (Sigma C8052) was incubated 
together with cholera toxin inhibitors (titration) for 4 h at rt  
followed by staining of the organoids with 3 X/ calcein AM 
(Invitrogen) for 15-30 min prior to organoid stimulation. 
Organoid swelling was monitored using the Zeiss LSM 800 
confocal microscope (images were taken every 15 min during 
cholera/inhibitor stimulation and every 10 min during forskolin 
stimulation) while the organoids were kept at 37°C/5% CO2. 
Organoid area increase (2D) was analyzed using Zen Blue 2.0 
analysis software, and area under the curve (AUC) calculations 
(of the total area increase measured in 4h) were conducted with 
GraphPad Prism 5.0.
CTB expression and purification 
Cells from a glycerol stock of Vibrio sp60 harbouring plasmid 
pATA13 were used to inoculate growth medium (100 mL, 
25 g L-1 LB mix, 15 g L-1 NaCl, 100 µg/mL ampicillin). The culture 
was grown overnight at 30 °C with shaking at 200 rpm, then 
used to inoculate fresh growth medium (6 x 1 L, 25 g L-1 LB mix, 
15 g L-1 NaCl, ampicillin 100 µg mL-1). These cultures were 
incubated at 30 °C with shaking at 200 rpm until A600 reached 
0.6 before the protein expression was induced by addition of 
isopropyl ]"D-1-thiogalactopyranoside to a concentration of 0.5 
mM. Cultures were incubated (30 °C, 200 rpm) for a further 24 
h, then cells were removed by centrifugation (7500g, 15 min). 
The combined supernatant was treated with ammonium 
sulphate (550 g L-1) and left to stir at 5 °C overnight. Crude 
protein was isolated by centrifugation (17,000g, 25 min) and 
redissolved in in 100 mM NaH2PO4, pH 7.0, 500 mM NaCl (60 
mL). Insoluble material was removed by centrifugation (5000g, 
10 min) before the solution was passed through a 0.22 µm filter 
then loaded onto a lactose-sepharose 6B column and eluted 
with 300 mM lactose, 100 mM NaH2PO4, pH 7.0, 500 mM NaCl. 
CTB was dialysed against PBS, pH 7.4, freeze-dried and stored at 
-80 °C.
Expression of EGCaseII24 
A synthetic gene for endoglycosylceramidase from Rhodococcus 
sp. M-777) bearing an N-terminal His-tag and codon-optimised 
for expression in E. coli in a pET28a backbone was purchased 
from Genscript (Piscataway, USA). Cells from glycerol stock (E. 
coli BL21 (DE3) gold) were used to inoculate TYP broth (100 mL, 
16 g L-1 tryptone, 16 g L-1 yeast, 5 g L-1 NaCl, 2.5 g L-1 K2HPO4, 50 
µg mL-1 kanamycin) and the culture was grown at 37 °C with 
shaking at 200 rpm overnight. The temperature was decreased 
to 20 °C before protein expression was induced by addition of 
isopropyl ]"D-1-thiogalactopyranoside to a final concentration 
of 0.1 mM. The culture was incubated at 20 °C with shaking at 
200 rpm for 7.5 h before cells were isolated by centrifugation 
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(5000g, 10 min) and cell pellets stored at -20 °C overnight. Cell 
pellets were resuspended in BugBuster (5 mL) and left at room 
temperature for 30 min before cell debris was removed by 
centrifugation (5000g, 15 min) and supernatant was applied to 
a Ni-NTA column which had been pre-equilibrated with 20 mM 
Na2HPO4, pH 7.0, 0.5 M NaCl. The flow-through was passed 
through the column again, before the column was washed with 
20 mM Na2HPO4, pH 7.0, 0.5 M NaCl (20 mL), then eluted with 
a stepwise imidazole gradient (10 mL aliquots: 50, 100, 200 300, 
400, 500 mM imidazole) in the same buffer. Elutions at 100 mM 
and 200 mM imidazole were combined and dialysed against 20 
mM Na2HPO4, pH 7.0, 0.5 M NaCl. ECGaseII was concentrated 
to 100 µM, divided into 50 µL aliquots and stored at -80 °C.
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